Business Daily Media

Business Marketing

.

Two Products of Zhaoke Ophthalmology (6622.HK) Passed The On-Site Inspection for Drug Registration of The National Medical Products Administration and The GMP Compliance Inspection of The Guangdong Medical Products Administration

  • Written by ACN Newswire - Press Releases
HONG KONG, May 24, 2021 - (ACN Newswire) - Zhaoke Ophthalmology Limited ("Zhaoke Ophthalmology" or the "Company"; stock code: 6622), an ophthalmic pharmaceutical company dedicated to the research, development and commercialization of therapies that address significant unmet medical needs, announced that on 13 May 2021, two pharmaceutical products

Read more //?#

Popular

Designing a Website in 2021: 4 Essential Tips for Success

Are you ready to design a website for your business? Ultimately, it is an integral element for any company these days – whether you sell online or operate out of a traditional brick-and-mortar store. A website supplies visibilit...

OpenText Security Solutions Announces Nastiest Malware of 2022

Analysis Reveals the Emergence of Triple Extortion and a Possible End to the Hacker Holiday  OpenText™ (NASDAQ: OTEX), (TSX: OTEX), today announced the Nastiest Malware of 2022, a ranking of the year’s biggest cyber threats. Fo...

The birth and the future of the unmanned industry

A brief history When we think of drones or UAVs, we have an image which readily jumps to mind, usually of a remote-controlled quadcopter of some sort, or of some other aerial vehicle, such as the US military’s Predator or Reape...